5 Comments
User's avatar
Richard B.'s avatar

I know about a few people who had eye surgery (visual correction or cataract removal). Generally the reception was positive and I think that these procedures have reached a threshold of ease of operation, safety and cost where more people are getting interested.

The competition in the sector is high - as you wrote in your article. Funnily, Baviera opened the most new clinics in Spain, where the competitive pressure is the lowest. The company is now definitely on my watchlist.

JB Peter's avatar

Thank you Richard, the competition is local and Baviera has still a lot of room to grow and should be able to manage the competition.

Joe | Goldman Won't Cover This's avatar

The Chinese stake is really putting me off here. Otherwise this would be right up my alley.

JB Peter's avatar

I had also a reaction at first. But then, I didn’t see what could badly affect the stock.

(It’s detailed in the article).

Joe | Goldman Won't Cover This's avatar

Yeah I read that. Your analysis is very reasonable. It still doesn't sit quiet right with me. Will have to think on it 🤔